Abstract
Glucose is the main substrate for energy metabolism of the brain, and the regional cerebral metabolic rate is directly related to regional brain activity. Therefore, the measurement of regional glucose metabolism is of great importance for the assessment of regional normal function and of pathological changes. Quantitation of glucose metabolism by PET is based on the 2-deoxyglucose method developed by Sokoloff and colleagues: F18-labelled deoxyglucose (FDG) is transported into the brain and phosphorylated, but cannot be further metabolised and therefore is accumulated intracellularly. The concentration of the tracer can be measured three dimensionally by PET, and together with the arterial tracer concentration, the kinetics of glucose uptake can be assessed, and the regional cerebral metabolic rates for glucose (rCMRGlc) can be calculated.
rCMRGlc is high in cortex and grey matter structures and low in white matter, but there are significant differences among various regions. Metabolic rate is slightly reduced with ageing and changed by sleep, dream, and functional activation. CMRGlc is significantly affected in pathological states, and the regional and global changes are important for assessing the severity of disorders and for differential diagnosis of diseases of the brain. Therefore, FDG-PET has still great importance in brain research and many applications in clinical neurology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Attwell D, Laughlin SB (2001) An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21(10):1133–1145
Berti V, Mosconi L, Pupi A (2014) Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging. PET Clin 9(2):129–140
Blomqvist G, Seitz RJ, Sjogren I, Halldin C, Stone-Elander S, Widen L et al (1994) Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomography. Acta Physiol Scand 151(1):29–43
Blomqvist G, Stone-Elander S, Halldin C, Roland PE, Widen L, Lindqvist M et al (1990) Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucose. J Cereb Blood Flow Metab 10(4):467–483
Bohnen NI, Djang DS, Herholz K, Anzai Y, Minoshima S (2012) Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med 53(1):59–71
Bonte S, Vandemaele P, Verleden S, Audenaert K, Deblaere K, Goethals I et al (2017) Healthy brain ageing assessed with 18F-FDG PET and age-dependent recovery factors after partial volume effect correction. Eur J Nucl Med Mol Imaging 44(5):838–849
Broski SM, Goenka AH, Kemp BJ, Johnson GB (2018) Clinical PET/MRI: 2018 update. Am J Roentgenol 211(2):295–313
Bunevicius A, Yuan H, Lin W (2013) The potential roles of 18F-FDG-PET in management of acute stroke patients. Biomed Res Int 2013:634598
Catana C, Drzezga A, Heiss WD, Rosen BR (2012) PET/MRI for neurologic applications. J Nucl Med 53(12):1916–1925
Cavaliere C, Longarzo M, Fogel S, Engstrom M, Soddu A (2020) Neuroimaging of narcolepsy and primary hypersomnias. Neuroscientist:1073858420905829
Chetelat G, Landeau B, Salmon E, Yakushev I, Bahri MA, Mezenge F et al (2013) Relationships between brain metabolism decrease in normal aging and changes in structural and functional connectivity. NeuroImage 76:167–177
Chiaravalloti A, Micarelli A, Ricci M, Pagani M, Ciccariello G, Bruno E et al (2019) Evaluation of task-related brain activity: is there a role for (18)F FDG-PET imaging? Biomed Res Int 2019:4762404
Chierichetti F, Pizzolato G (2012) 18F-FDG-PET/CT. Q J Nucl Med Mol Imaging 56(2):138–150
Choo IH, Ni R, Scholl M, Wall A, Almkvist O, Nordberg A (2013) Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer’s disease in mild cognitive impairment patients. J Alzheimers Dis 33(4):929–939
Chugani HT, Phelps ME, Mazziotta JC (1987) Positron emission tomography study of human brain functional development. Ann Neurol 22(4):487–497
Clarke D, Sokoloff L (1999) Circulation and energy metabolism of the brain. In: Siegel GJ (ed) Basic neurochemistry: molecular, cellular, and medical aspects, 6th edn. Lippincott Williams & Wilkins, Philadelphia, p xxi, 1183 p
Drzezga A (2009) Diagnosis of Alzheimer’s disease with [18F]PET in mild and asymptomatic stages. Behav Neurol 21(1):101–115
Drzezga A, Altomare D, Festari C, Arbizu J, Orini S, Herholz K et al (2018) Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease. Eur J Nucl Med Mol Imaging 45(9):1487–1496
Duara R, Grady C, Haxby J, Ingvar D, Sokoloff L, Margolin RA et al (1984) Human brain glucose utilization and cognitive function in relation to age. Ann Neurol 16(6):703–713
Fox PT, Raichle ME, Mintun MA, Dence C (1988) Nonoxidative glucose consumption during focal physiologic neural activity. Science 241(4864):462–464
Garibotto V, Herholz K, Boccardi M, Picco A, Varrone A, Nordberg A et al (2017) Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer’s disease in the context of a structured 5-phase development framework. Neurobiol Aging 52:183–195
Hahn A, Gryglewski G, Nics L, Hienert M, Rischka L, Vraka C et al (2016) Quantification of task-specific glucose metabolism with constant infusion of 18F-FDG. J Nucl Med 57(12):1933–1940
Hawkins RA, Phelps ME, Huang SC, Kuhl DE (1981) Effect of ischemia on quantification of local cerebral glucose metabolic rate in man. J Cereb Blood Flow Metab 1(1):37–51
Heiss WD (2009a) WSO Leadership in Stroke Medicine Award Lecture Vienna, September 26, 2008: functional imaging correlates to disturbance and recovery of language function. Int J Stroke 4(2):129–136
Heiss WD (2009b) The potential of PET/MR for brain imaging. Eur J Nucl Med Mol Imaging 36(Suppl 1):S105–S112
Heiss WD (2018) The additional value of PET in the assessment of cerebral small vessel disease. J Nucl Med 59(11):1660–1664
Heiss WD, Habedank B, Klein JC, Herholz K, Wienhard K, Lenox M et al (2004) Metabolic rates in small brain nuclei determined by high-resolution PET. J Nucl Med 45(11):1811–1815
Heiss WD, Huber M, Fink GR, Herholz K, Pietrzyk U, Wagner R et al (1992) Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 12(2):193–203
Heiss WD, Pawlik G, Herholz K, Wagner R, Goldner H, Wienhard K (1984) Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab 4(2):212–223
Heiss WD, Pawlik G, Herholz K, Wagner R, Wienhard K (1985) Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming. Brain Res 327(1–2):362–366
Heiss WD, Raab P, Lanfermann H (2011) Multimodality assessment of brain tumors and tumor recurrence. J Nucl Med 52(10):1585–1600
Heiss WD, Zimmermann-Meinzingen S (2012) PET imaging in the differential diagnosis of vascular dementia. J Neurol Sci 322(1–2):268–273
Herholz K (2017) Brain tumors: an update on clinical PET research in gliomas. Semin Nucl Med 47(1):5–17
Herholz K, Herscovitch P, Heiss WD (2013) NeuroPET positron emission tomography in neuroscience and clinical neurology. Springer, Berlin
Herholz K, Langen KJ, Schiepers C, Mountz JM (2012) Brain tumors. Semin Nucl Med 42(6):356–370
Hsieh TC, Lin WY, Ding HJ, Sun SS, Wu YC, Yen KY et al (2012) Sex- and age-related differences in brain FDG metabolism of healthy adults: an SPM analysis. J Neuroimaging 22(1):21–27
Jiang J, Sun Y, Zhou H, Li S, Huang Z, Wu P et al (2018) Study of the influence of age in (18)F-FDG PET images using a data-driven approach and its evaluation in Alzheimer’s disease. Contrast Media Mol Imaging 2018:3786083
Jones T, Rabiner EA, Company PETRA (2012) The development, past achievements, and future directions of brain PET. J Cereb Blood Flow Metab 32(7):1426–1454
Juaristi I, Contreras L, Gonzalez-Sanchez P, Perez-Liebana I, Gonzalez-Moreno L, Pardo B et al (2019) The response to stimulation in neurons and astrocytes. Neurochem Res 44(10):2385–2391
Kalpouzos G, Chetelat G, Baron JC, Landeau B, Mevel K, Godeau C et al (2009) Voxel-based map** of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 30(1):112–124
Kelly PJ, Camps-Renom P, Giannotti N, Marti-Fabregas J, Murphy S, McNulty J et al (2019) Carotid plaque inflammation imaged by (18)F-Fluorodeoxyglucose positron emission tomography and risk of early recurrent stroke. Stroke 50(7):1766–1773
Kety SS, Schmidt CF (1948) The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 27(4):476–483
Kuhl DE, Metter EJ, Riege WH, Phelps ME (1982) Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method. J Cereb Blood Flow Metab 2(2):163–171
Kuwabara H, Evans AC, Gjedde A (1990) Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose. J Cereb Blood Flow Metab 10(2):180–189
Lotan E, Friedman KP, Davidson T, Shepherd TM (2020) Brain 18F-FDG-PET: utility in the diagnosis of dementia and epilepsy. Isr Med Assoc J 22(3):178–184
Madsen PL, Hasselbalch SG, Hagemann LP, Olsen KS, Bulow J, Holm S et al (1995) Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: evidence obtained with the Kety-Schmidt technique. J Cereb Blood Flow Metab 15(3):485–491
Magistretti PJ, Allaman I (2015) A cellular perspective on brain energy metabolism and functional imaging. Neuron 86(4):883–901
Mangold R, Sokoloff L, Conner E, Kleinerman J, Therman PO, Kety SS (1955) The effects of sleep and lack of sleep on the cerebral circulation and metabolism of normal young men. J Clin Invest 34(7, Part 1):1092–1100
Marnane M, Merwick A, Sheehan OC, Hannon N, Foran P, Grant T et al (2012) Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. Ann Neurol 71(5):709–718
Meles SK, Renken RJ, Pagani M, Teune LK, Arnaldi D, Morbelli S et al (2020) Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts. Eur J Nucl Med Mol Imaging 47(2):437–450
Meyer PT, Frings L, Rucker G, Hellwig S (2017) (18)F-FDG PET in Parkinsonism: differential diagnosis and evaluation of cognitive impairment. J Nucl Med 58(12):1888–1898
Mintun MA, Lundstrom BN, Snyder AZ, Vlassenko AG, Shulman GL, Raichle ME (2001) Blood flow and oxygen delivery to human brain during functional activity: theoretical modeling and experimental data. Proc Natl Acad Sci U S A 98(12):6859–6864
Nasu S, Hata T, Nakajima T, Suzuki Y (2002) Evaluation of 18F-FDG PET in acute ischemic stroke: assessment of hyper accumulation around the lesion. Kaku Igaku 39(2):103–110
Nofzinger EA, Mintun MA, Wiseman M, Kupfer DJ, Moore RY (1997) Forebrain activation in REM sleep: an FDG PET study. Brain Res 770(1-2):192–201
Pakkenberg B, Gundersen HJ (1997) Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 384(2):312–320
Pardridge WM, Oldendorf WH (1977) Transport of metabolic substrates through the blood-brain barrier. J Neurochem 28(1):5–12
Patlak CS, Blasberg RG, Fenstermacher JD (1983) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 3(1):1–7
Pawlik G, Heiss WD (1989) Positron emission tomography and neuropsychological function. In: Bigler ED, Yeo RA, Turkheimer E (eds) Neuropsychological function and brain imaging. Springer, New York, NY, pp 65–138
Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6(5):371–388
Phelps ME, Mazziotta JC, Kuhl DE, Nuwer M, Packwood J, Metter J et al (1981) Tomographic map** of human cerebral metabolism visual stimulation and deprivation. Neurology 31(5):517–529
Portnow LH, Vaillancourt DE, Okun MS (2013) The history of cerebral PET scanning: from physiology to cutting-edge technology. Neurology 80(10):952–956
Raichle ME, Larson KB, Phelps ME, Grubb RL Jr, Welch MJ, Ter-Pogossian MM (1975) In vivo measurement of brain glucose transport and metabolism employing glucose--11C. Am J Phys 228(6):1936–1948
Raichle ME, Mintun MA (2006) Brain work and brain imaging. Annu Rev Neurosci 29:449–476
Reivich M, Alavi A, Wolf A, Fowler J, Russell J, Arnett C et al (1985) Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab 5(2):179–192
Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T et al (1979) The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44(1):127–137
Shen X, Liu H, Hu Z, Hu H, Shi P (2012) The relationship between cerebral glucose metabolism and age: report of a large brain PET data set. PLoS One 7(12):e51517
Shepherd TM, Nayak GK (2019) Clinical use of integrated positron emission tomography-magnetic resonance imaging for dementia patients. Top Magn Reson Imaging 28(6):299–310
Shiyam Sundar LK, Muzik O, Rischka L, Hahn A, Lanzenberger R, Hienert M et al (2020) Promise of fully integrated PET/MRI: noninvasive clinical quantification of cerebral glucose metabolism. J Nucl Med 61(2):276–284
Siesjo BK (1978) Brain energy metabolism and catecholaminergic activity in hypoxia, hypercapnia and ischemia. J Neural Transm Suppl 14:17–22
Silverman DHS, Melega WP (2004) Molecular imaging of biologic processes with PET: evaluation biologic bases of cerebral function. In: MEPD P (ed) Pet: molecular imaging and its biological applications. Springer, pp 509–583
Sokoloff L (1989) Circulation and energy metabolism of the brain. In: Siegel GJ (ed) Basic neurochemistry: molecular, cellular, and medical aspects, 4th edn. Raven Press, New York, p xviii. 984 p
Sokoloff L (1999) Energetics of functional activation in neural tissues. Neurochem Res 24(2):321–329
Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD et al (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28(5):897–916
Tondo G, Esposito M, Dervenoulas G, Wilson H, Politis M, Pagano G (2019) Hybrid PET-MRI applications in movement disorders. Int Rev Neurobiol 144:211–257
Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, Raichle ME (2010) Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci U S A 107(41):17757–17762
Villien M, Wey HY, Mandeville JB, Catana C, Polimeni JR, Sander CY et al (2014) Dynamic functional imaging of brain glucose utilization using fPET-FDG. NeuroImage 100:192–199
von Oertzen TJ (2018) PET and ictal SPECT can be helpful for localizing epileptic foci. Curr Opin Neurol 31(2):184–191
Wienhard K, Pawlik G, Herholz K, Wagner R, Heiss WD (1985) Estimation of local cerebral glucose utilization by positron emission tomography of [18F]2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures. J Cereb Blood Flow Metab 5(1):115–125
Wu HM, Bergsneider M, Glenn TC, Yeh E, Hovda DA, Phelps ME et al (2003) Measurement of the global lumped constant for 2-deoxy-2-[18F]fluoro-D-glucose in normal human brain using [15O]water and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography imaging. A method with validation based on multiple methodologies. Mol Imaging Biol 5(1):32–41
Wyss MT, Jolivet R, Buck A, Magistretti PJ, Weber B (2011) In vivo evidence for lactate as a neuronal energy source. J Neurosci 31(20):7477–7485
Disclosures
Wolf-Dieter Heiss and Olivier Zaro-Weber were funded by the WDH Foundation and the Marga and Walter Boll Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Heiss, WD., Zaro-Weber, O. (2021). Cerebral Glucose Metabolism. In: Dierckx, R.A., Otte, A., de Vries, E.F., van Waarde, A., Lammertsma, A.A. (eds) PET and SPECT of Neurobiological Systems. Springer, Cham. https://doi.org/10.1007/978-3-030-53176-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-53176-8_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-53175-1
Online ISBN: 978-3-030-53176-8
eBook Packages: MedicineMedicine (R0)